TALOPH(SH:600222) Sou Hu Cai Jing·2025-05-15 22:48Summary of Key Points Core Viewpoint - Tai Long Pharmaceutical (600222) has reported a slight decline in stock price, with significant movements in capital flow and a recent guarantee announcement from its subsidiary [1][2]. Trading Information - As of May 15, 2025, Tai Long Pharmaceutical's stock closed at 5.32 yuan, down 0.19%, with a turnover rate of 1.16% and a trading volume of 66,600 shares, resulting in a transaction value of 35.35 million yuan [1]. - On the same day, the capital flow showed a net outflow of 2.80 million yuan from main funds, accounting for 7.92% of the total transaction value. Meanwhile, retail investors contributed a net inflow of 1.71 million yuan, representing 4.82% of the total [2][4]. Company Announcements - Tai Long Pharmaceutical announced that its subsidiary, Tong Jun Tang Pharmaceutical Co., Ltd., has provided a joint liability guarantee for a credit facility not exceeding 120 million yuan from China Everbright Bank [2]. - As of the announcement date, the total amount of guarantees provided by Tong Jun Tang is 120 million yuan. The company is seeking a total credit facility of up to 2 billion yuan from banks and financial institutions for 2025, which does not require board or shareholder approval [2]. - Recent financial indicators show that as of March 31, 2025, the total assets of Tai Long Pharmaceutical were 356.55 million yuan, with total liabilities of 193.45 million yuan and net assets attributable to shareholders of 157.84 million yuan [2].